Biopsy: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Biopsy
Largest movements
- Cash -€87,597
down €87,597 (-54.7%), from €160,284 to €72,687
mainly Contributions, distributions and other (-€218,775) and Current investments (-€19,000)
- Current investments +€19,000
new in 2025: €19,000
- Intangible fixed assets -€7,750
down €7,750 (-40.0%), from €19,375 to €11,625
- Tangible fixed assets +€6,352
up €6,352 (+127%), from €4,996 to €11,348
- Receivables within one year -€2,357
down €2,357 (-18.9%), from €12,448 to €10,091
of which Trade receivables: -€12,100
- Profit (loss) carried forward -€77,768
no longer reported in 2025 (was €77,768)
- Other debts +€5,612
up €5,612 (+5.7%), from €99,120 to €104,732
- Gross operating margin -€45,226
down €45,226 (-18.1%), from €250,070 to €204,844
- Taxes -€14,756
down €14,756 (-26.8%), from €55,035 to €40,279
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €201,620 | €129,565 | -€72,055 | -35.7% |
| Fixed assets | 21/28 | €24,371 | €22,973 | -€1,398 | -5.7% |
| Intangible fixed assets | 21 | €19,375 | €11,625 | -€7,750 | -40.0% |
| Tangible fixed assets | 22/27 | €4,996 | €11,348 | +€6,352 | +127% |
| Furniture and vehicles | 24 | €4,996 | €11,348 | +€6,352 | +127% |
| Current assets | 29/58 | €177,249 | €106,592 | -€70,657 | -39.9% |
| Amounts receivable within one year | 40/41 | €12,448 | €10,091 | -€2,357 | -18.9% |
| Trade receivables | 40 | €12,100 | - | -€12,100 | |
| Other amounts receivable | 41 | €348 | €10,091 | +€9,743 | +2,800% |
| Current investments | 50/53 | - | €19,000 | +€19,000 | |
| Cash at bank and in hand | 54/58 | €160,284 | €72,687 | -€87,597 | -54.7% |
| Deferred charges and accrued income | 490/1 | €4,517 | €4,814 | +€297 | +6.6% |
| Total equity and liabilities | 10/49 | €201,620 | €129,565 | -€72,055 | -35.7% |
| Equity | 10/15 | €98,228 | €20,460 | -€77,768 | -79.2% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €1,860 | €1,860 | = | 0.0% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,860 | €1,860 | = | 0.0% |
| Profit (loss) carried forward | 14 | €77,768 | - | -€77,768 | |
| Amounts payable | 17/49 | €103,392 | €109,105 | +€5,713 | +5.5% |
| Amounts payable within one year | 42/48 | €103,392 | €109,105 | +€5,713 | +5.5% |
| Trade debts | 44 | €3,453 | €2,072 | -€1,381 | -40.0% |
| Suppliers | 440/4 | €3,453 | €2,072 | -€1,381 | -40.0% |
| Taxes, remuneration and social security | 45 | €819 | €2,301 | +€1,482 | +181% |
| Taxes | 450/3 | €819 | - | -€819 | |
| Remuneration and social security | 454/9 | - | €2,301 | +€2,301 | |
| Other amounts payable | 47/48 | €99,120 | €104,732 | +€5,612 | +5.7% |
| Remuneration, social security and pensions | 62 | €13,692 | €12,141 | -€1,551 | -11.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €8,718 | €9,223 | +€505 | +5.8% |
| Other operating charges | 640/8 | €1,163 | €352 | -€811 | -69.7% |
| Gross operating margin | 9900 | €250,070 | €204,844 | -€45,226 | -18.1% |
| Operating profit (loss) | 9901 | €226,497 | €183,128 | -€43,369 | -19.1% |
| Financial income | 75/76B | €1,277 | €73 | -€1,204 | -94.3% |
| Recurring financial income | 75 | €1,277 | €73 | -€1,204 | -94.3% |
| Financial charges | 65/66B | €854 | €1,915 | +€1,061 | +124% |
| Recurring financial charges | 65 | €854 | €1,915 | +€1,061 | +124% |
| Profit (loss) for the period before taxes | 9903 | €226,920 | €181,286 | -€45,634 | -20.1% |
| Income taxes | 67/77 | €55,035 | €40,279 | -€14,756 | -26.8% |
| Profit (loss) for the period | 9904 | €171,885 | €141,007 | -€30,878 | -18.0% |
| Profit (loss) for the period to be appropriated | 9905 | €171,885 | €141,007 | -€30,878 | -18.0% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 14 October 2026 via checked.be.